Wednesday, February 10, 2010, 4:51pm SGT - The Singapore stock market closes in 9 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Array BioPharma, Inc. (ARRY)

At 5:00AM SGT: 2.40 USD   0.00 (0.00%)  
 MORE ON ARRY 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Array BioPharma Inc. (NGM:ARRY) Delayed quote dataEdit
Last Trade:2.40 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:2.40
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:5.61
Day's Range:N/A - N/A
52wk Range:1.68 - 4.65
Volume:0
Avg Vol (3m):635,533
Market Cap:118.34M
P/E (ttm):N/A
EPS (ttm):-2.48
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add ARRY to Portfolio   Download Data

 HEADLINES 
•ARRAY BIOPHARMA INC Financials
EDGAR Online Financials (Sat, Feb 6)
•Dow down 26; Array BioPharma up 7%
at bizjournals.com (Thu, Feb 4)
•Beacon Equity Issues BioPharmaceutical Stock Alert for Array BioPharma Inc.
GlobeNewswire (Wed, Feb 3)
•Lower Q2 Loss for Array Bio
Zacks.com (Wed, Feb 3)
•Array BioPharma Inc. F2Q10 (Qtr End 12/31/09) Earnings Call Transcript
at Seeking Alpha (Wed, Feb 3)
•Array BioPharma, Sterling Financial: Early Volume Plays
at TheStreet.com (Tue, Feb 2)
•New Star Analyst Rankings for Array BioPharma Inc.
StarMine (Tue, Feb 2)
•ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Feb 2)
•UPDATE - Array BioPharma posts smaller-than-expected Q2 loss
at Reuters (Tue, Feb 2)
•ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
EDGAR Online (Tue, Feb 2)
•Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2010
Business Wire (Tue, Feb 2)
More Headlines for ARRY...
 ANALYST 
EPS Est (next year) (Jun-10) :-2.01
EPS Est (in 2 years) (Jun-11) :-1.81
Avg Rec (current)*:2.1
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer, inflammatory, and metabolic diseases in North America, Europe, and Asia Pacific.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices